| Identification |
| Name: | Tricyclo[3.3.1.13,7]decan-1-amine,3,5-dimethyl- |
| Synonyms: | 1-Adamantanamine,3,5-dimethyl- (8CI);1,3-Dimethyl-5-aminoadamantane;1-Amino-3,5-dimethyladamantane;3,5-Dimethyl-1-adamantylamine;Alzantin;D 145;D 145 (sympathomimetic);DMAA;DRG 0267;Ebixa; |
| CAS: | 19982-08-2 |
| Molecular Formula: | C12H21N |
| Molecular Weight: | 179.3 |
| InChI: | InChI=1/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3 |
| Molecular Structure: |
 |
| Properties |
| Melting Point: | 153 |
| Density: | 1.046 |
| Stability: | Stable under normal temperatures and pressures. |
| Refractive index: | 1.4941 (20 C) |
| Solubility: | Soluble |
| Appearance: | White powder. |
| Biological Activity: | An antagonist at the NMDA receptor, binding to the ion channel site. Used in the treatment of Parkinsonism. |
| Storage Temperature: | Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. |
| Usage: | Sympathomimetic. |
| Safety Data |
| Hazard Symbols |
Xi: Irritant
|
| |
 |
